Related Experiment Video
Updated: May 25, 2026
08:33
Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
Published on: March 11, 2021
P1 (adenosine) purinoceptor assays
S Jamal Mustafa1, Habib R Ansari, Worku Abebe
1Robert C. Byrd Health Science Center, West Virginia University, Morgantown, West Virginia, USA.
Current Protocols in Pharmacology
|February 2, 2012
Summary
Adenosine (ADO) receptors mediate ADO's biological effects via four subtypes. This unit describes isolated tissue assays for pharmacologically characterizing these ADO receptor subtypes.
Area of Science:
- Pharmacology
- Molecular Biology
- Physiology
Background:
- Adenosine (ADO) receptors are key mediators of the endogenous nucleoside ADO and its analogs.
- Four ADO receptor subtypes (A(1), A(2A), A(2B), and A(3)) exist, each with distinct signaling pathways.
- Understanding ADO receptor pharmacology is crucial for developing targeted therapeutics.
Purpose of the Study:
- To describe methodologies for the pharmacological characterization of adenosine (ADO) receptors.
- To detail the use of isolated tissue assays for functional response analysis.
- To provide a framework for identifying and differentiating ADO receptor subtypes.
Main Methods:
- Utilized isolated tissue assays for pharmacological characterization.
- Employed functional responses to assess ADO receptor activity.
- Examined specific tissues including guinea pig atrium, pig coronary artery, guinea pig aorta, and mouse aorta.
Main Results:
- Established protocols for the functional assessment of ADO receptor subtypes in various tissues.
- Demonstrated the utility of isolated tissue assays in distinguishing receptor pharmacology.
- Provided a basis for subtype-specific ADO receptor investigation.
Conclusions:
- Isolated tissue assays are effective for the pharmacological characterization of adenosine (ADO) receptors.
- Functional responses in specific tissues allow for the differentiation of ADO receptor subtypes.
- These methods are foundational for further research into ADO receptor signaling and drug development.
Related Concept Videos
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:27Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...